Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations
- 4 October 2002
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 106 (5), 323-330
- https://doi.org/10.1034/j.1600-0447.2002.01331.x
Abstract
Objective: To review the literature on efficacy and risks of combining antipsychotics (atypical with atypical or conventional) and suggest a rationale and strategies for future clinical trials. Meth...Keywords
This publication has 46 references indexed in Scilit:
- Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- The Emerging Role of Glutamate in the Pathophysiology and Treatment of SchizophreniaAmerican Journal of Psychiatry, 2001
- Clozapine and risperidone: combination/ augmentation treatment of refractory schizophrenia: a preliminary observationActa Psychiatrica Scandinavica, 2000
- Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret?The Journal of Clinical Psychiatry, 1999
- Mortality in schizophreniaThe British Journal of Psychiatry, 1998
- Evaluation of Treatment-Resistant SchizophreniaSchizophrenia Bulletin, 1997
- The Genetics of Personality DisorderThe British Journal of Psychiatry, 1992
- Clozapine in China: a review and preview of US/PRC collaborationPsychopharmacology, 1989
- Determining Optimal Therapy — Randomized Trials in Individual PatientsNew England Journal of Medicine, 1986
- The long-term course of the schizophrenic psychosesPsychological Medicine, 1974